Form 8-K RTI SURGICAL, INC. For: Oct 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold
October 30, 2015 8:07 AM EDTCanaccord Genuity downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $4.40 yesterday.
... MoreRTI Surgical (RTIX) Reports In-Line Q3 EPS; Trims FY15 Outlook
October 29, 2015 9:09 AM EDTRTI Surgical (NASDAQ: RTIX) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $66.5 million versus the consensus estimate of $69.53 million.
RTI Surgical sees FY2015 EPS of $0.19, versus prior guidance of $0.20-$0.23 and the consensus of... More



